Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT
(2019)
Journal Article
Knight, M., Chiocchia, V., Partlett, C., Rivero-Arias, O., Hua, X., Bowler, U., Gray, J., Gray, S., Hinshaw, K., Khunda, A., Moore, P., Mottram, L., Owino, N., Pasupathy, D., Sanders, J., Sultan, A. H., Thakar, R., Tuffnell, D., Linsell, L., & Juszczak, E. (2019). Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT. Health Technology Assessment, 23(54), 1-54. https://doi.org/10.3310/hta23540
Background
Sepsis is a leading cause of direct and indirect maternal death in both the UK and globally. All forms of operative delivery are associated with an increased risk of sepsis, and the National Institute for Health and Care Excellence’s guid...
Read More about Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT.